FDA clears Riverain's updated chest CAD technology

Justine Varieur Cadet | | Health Exec | EMR/EHR
The FDA has granted approval for Riverain Medical’s newest version of the OnGuard chest x-ray computer-aided detection (CAD) technology.

OnGuard identifies solitary pulmonary nodules that may represent early-stage lung cancer on an existing chest x-ray, according to the Dayton, Ohio-based company. Because OnGuard utilizes the existing digital chest x-ray, Riverain added that there is no additional radiation dose, patient procedure, hardware or standalone workstation needed to integrate the CAD technology into a radiology department.

Justine Varieur Cadet

Related Content

Private equity-backed cardiology group puts cloud-based technology in hands of its cardiologists
AI helps cardiologists deliver personalized healthcare—but there is still plenty of work to do
Indiana hospitals reduce nuisance alerts by 77% with medication decision support software
Leveraging machine learning to rapidly create clinical AI algorithms
How medication reconciliation data consolidation in the EHR enables better patient care
How are the best in KLAS Health IT vendor rankings created?

Around the web

Cardiovascular Business
Payment cuts and beyond: Key takeaways for cardiologists from the 2025 Medicare Physician Fee Schedule

The American College of Cardiology has shared its perspective on new CMS payment policies, highlighting revenue concerns while providing key details for cardiologists and other cardiology professionals. 

AI in Healthcare
A modest proposal to rally AI regulators around a simple game plan

As debate simmers over how best to regulate AI, experts continue to offer guidance on where to start, how to proceed and what to emphasize. A new resource models its recommendations on what its authors call the “SETO Loop.”

Cardiovascular Business
FDA commissioner urges clinicians to join fight against medical misinformation

FDA Commissioner Robert Califf, MD, said the clinical community needs to combat health misinformation at a grassroots level. He warned that patients are immersed in a "sea of misinformation without a compass."

Design by Adaptive Theme
Trimed Popup
Trimed Popup